Global regulators celebrate 10 years of strategic leadership and cooperation
Global regulators celebrate 10 years of strategic leadership and cooperation
Global regulators celebrate 10 years of strategic leadership and cooperation
Human medicines European public assessment report (EPAR): Vfend, voriconazole, Candidiasis;Mycoses;Aspergillosis, Date of authorisation: 19/03/2002, Revision: 55, Status: Authorised
Marketing authorisation (veterinary medicines)
Referral procedures: veterinary medicines
Veterinary limited markets
Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers
Questions and answers on data requirements when replacing hydrofluorocarbons as propellants in oral pressurised metered dose inhalers
Academia
Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised
Withdrawn application: Gefzuris, gefapixant, Date of withdrawal: 14/07/2023, Initial authorisation